J.P. Morgan 2019

Meet with



Schedule a Meeting

January 7 - 10, 2019
The Westin St. Francis
San Francisco on Union Square
335 Powell Street

  • Chris Scully - EVP and Chief Financial Officer
  • Chris Fikry - EVP, Global Lab Services
  • Diem Nguyen - EVP, Biopharma Partnerships
  • Anshul Thakral - SVP and Global Head of PPD Biotech
  • Roger Smith - SVP and General Manager, Accelerated Enrollment Solutions
  • Bhooshi de Silva - SVP, Corporate Development and Strategy
  • Daniel Burch, M.D. - Global Medical Officer, PPD Biotech
  • Dawie Wessels, M.D. - Chief Medical Officer, Synexus
  • Andreia Racioppi - VP, Business Development
  • Dave Frakes, M.D. - VP, Regional Medical Officer, PPD Biotech
  • Scott Ballenger - VP, Business Development, Accelerated Enrollment Solutions
  • Stephen Scaldaferri - Executive Account Director, Business Development, PPD Biotech
  • Laura Batchelor - Director, Commercial Strategy and Analytics, PPD Biotech

David Simmons

Chairman and Chief Executive Officer

Schedule a Meeting

Members of the medical and executive leadership teams from PPD and PPD Biotech will be attending the J.P. Morgan 37th Annual Healthcare Conference in San Francisco, CA. This is a great opportunity to meet to discuss future outsourcing strategies. If you are interested in scheduling a meeting with us at J.P. Morgan, please complete the form below. All fields are required.

For more information, please contact:
Laura Batchelor
Director, Commercial Strategy and Analytics
PPD® Biotech

About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 20,000 employees worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

About PPD Biotech

PPD Biotech is a Phase I-IV CRO service provider devoted to biotech and small to mid-size pharma companies. Operating as a company within a company, we offer dedicated drug development resources who understand the unique needs of biotech companies.

We combine the global power and capabilities of PPD with the personal attention, flexibility and extensive knowledge of biotech operations you could previously only find at niche CROs. We stand ready to partner with you to drive your innovative therapies forward.

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2020 PPD, Inc. All Rights Reserved.